Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirabegron and Solifenacin vs Desmopressin in Children with Nocturnal Enuresis
NCT07199894Phase 3Recruiting
- Sponsor
- Mansoura University
- Start
- Dec 2024
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of mirabegron, solifenacin in nocturnal enuresis (NE), sponsored by Mansoura University. Started Dec 2024; status: recruiting.
02
Drugs
mirabegronsolifenacin
03
Conditions
nocturnal enuresis (NE)
Beyond the preview
Go deeper on NCT07199894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07199894.